Comparative evaluation of immunoassays to improve access to diagnosis for Chagas disease in Colombia

Abstract

The study indicated that several commercial assays accurately detect T. cruzi infection in Colombian patients. A simplified testing process with two commercial assays could perform comparably to the previous process, reducing cost and accessibility barriers and facilitating national scale-up.